Patients with trauma and lupus report significantly higher stress, but resilience and support may offer a buffer, with each additional positive factor linked to a 0.67 drop in perceived stress.
Intra-Cellular Therapies' breakthrough oral drug, lumateperone, has shown a remarkable 63% reduction in relapse risk for schizophrenia patients, offering hope for improved management of this pervasive condition.
The psychiatric safety of semaglutide 2.4 mg for weight management in adults with overweight or obesity was evaluated in a recent analysis, which found no increased risk of depression or suicidal thoughts, emphasizing the importance of mental health monitoring for patients undergoing weight management treatment.
A recent trial suggests potential cognitive health benefits and reductions in brain age from following a green-Mediterranean diet rich in polyphenols, particularly for individuals with diabetes.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Psychosis patients face up to 2.6 times higher mortality risk after prison release, with overdose and suicide leading the causes—highlighting critical gaps in post-release care.
Women with PCOS showed elevated emotional eating (39.0 ± 29.9 vs 33.1 ± 27.8) and uncontrolled eating (30.7 ± 19.4 vs 26.7 ± 18.2) at midlife compared to controls, with distinct patterns among phenotypes that could inform clinical screening.
A recent study investigates the impact of sexual trauma on mental health, revealing significantly elevated odds of schizophrenia, bipolar disorder, and major depressive disorder. #MentalHealthResearch